Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

The new tool helps measure the impact of alopecia areata on children's quality of life.

Higher concentrations of dithranol can help regrow hair in severe alopecia areata.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

Low input with cover crop optimizes yield and reduces greenhouse gas emissions.

A comprehensive scoring system for alopecia areata severity is needed.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Higher oxidative stress is linked to more severe alopecia areata.

Both emollients effectively reduced itching and improved skin moisture in xerotic eczema.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Current guidelines may overlook beard and sideburn involvement in diagnosing frontal fibrosing alopecia in men.

8-OHdG may help diagnose and assess alopecia areata.

Current methods for grading hair loss from cancer treatment are not accurate enough and need improvement.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Alopecia negatively affects quality of life and mental health.

Higher IL-21 levels may help predict alopecia areata activity.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Alopecia areata greatly affects quality of life, needing psychological support.

Acne and hair loss in women can greatly lower their quality of life, but having polycystic ovarian syndrome does not.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Low-dose oral minoxidil is effective and safe for treating male pattern baldness.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

A new treatment plan helps manage folliculitis decalvans effectively.